Targeting the microbiome to reduce persistent symptoms after treating inflammation in inflammatory bowel disease
Identify inflammatory bowel disease patients with quiescent disease sutiable for de-escalation of therapy
Identify pregnancies at risk for preterm birth using AI/ML models trained on microbiome data